Stories tagged 'Soheil Meshinchi'
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service
It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.
Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t-cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer , mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
Big data in cancer research
New study in childhood leukemia illustrates challenges and power of cutting-edge genomic technologies’ huge data sets
Dec. 21, 2017 | By Susan Keown / Fred Hutch News Service
Big data is the new reality in cancer research, yielding powerful insights into disease biology — as a recent study in pediatric leukemia showed. But how to store, share or even make sense of such vasts amounts of information?
‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment
Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’
Dec. 11, 2017 | By Susan Keown / Fred Hutch News Service
Researchers found key differences between the molecular signatures of AML in patients of different ages: So why should we keep assuming that therapies developed for the elderly will work for the young?
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Aug. 29, 2017 | By Sabrina Richards / Fred Hutch News Service
A unique, Hutch-based repository of tissue samples ‘ready to teach’ lifesaving lessons about childhood leukemia.
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
June 27, 2017 | by Susan Keown / Fred Hutch News Service
The leukemia drug gemtuzumab ozogamicin (Mylotarg) was pulled from the market seven years after initial approval. Now, new evidence may be bringing it back to life to treat a specific group of patients.
The quest to better understand the deadliest childhood leukemia
Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis
Dec. 7, 2016 | By Sabrina Richards / Fred Hutch News Service
Acute myeloid leukemia is the deadliest leukemia among children. Only 60 percent of patients will achieve long-term remission. But scientists see change on the horizon.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Six misconceptions about colorectal cancer
Luke Timmerman to scale Mount Everest for Fred Hutch research
A message from Dr. Gary Gilliland about cancer research in 2018
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
